医学
子宫内膜切除术
烧蚀
闭经
不利影响
安全概况
外科
内科学
遗传学
生物
怀孕
作者
Jay M. Cooper,Richard J. Gimpelson
出处
期刊:PubMed
日期:2004-04-01
卷期号:49 (4): 267-73
被引量:18
摘要
To provide an overview of the approved second-generation endometrial ablation technologies.Data from the FDA Summary of Safety and Effectiveness Data were compared for Thermachoice, HydroThermablator, Her Option and Novasure devices.At 12 months' follow-up, Novasure and HydroThermablator had the highest amenorrhea rates. Thermochoice and Novasure had the highest success rates at 12 months. Novasure had the lowest adverse event rates in the first 24 hours, between 24 hours and 2 weeks and between 2 weeks and 1 year of follow-up.Summary of Safety and Effectiveness Data, obtainable on the FDA Web site, offers objective data for comparing second-generation endometrial ablation technologies.
科研通智能强力驱动
Strongly Powered by AbleSci AI